{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:54:53Z","timestamp":1788864893521,"version":"build-2803163510"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Strongyloides stercoralis is considered to be historically endemic in Appalachia and the American South, but recent surveillance data, especially data evaluating strongyloidiasis associated with hospitalization, are lacking in most parts of the United States.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a population-based retrospective analysis on strongyloidiasis using the National Inpatient Sample from 2003 to 2018. Geographic distribution of strongyloidiasis associated hospitalization was assessed. Logistic regression was used to identify risk factors associated with strongyloidiasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 6931 hospitalizations associated with strongyloidiasis during the study period (11.8 per million hospitalizations). The rate of strongyloidiasis was highest in the Northeast US region, including the Middle Atlantic division (47.1 cases per million population; adjusted odds ratio, 2.00 [95% confidence interval: 1.58\u20132.53]), and the East South Central division (27.5 cases per million; adjusted odds ratio, 2.77 [2.02\u20133.80]). Older age, male sex, nonwhite race\/ethnicity (particularly Hispanic and Asian), nonprivate insurance, and residence in neighborhoods with low median income were also associated with strongyloidiasis. Immunocompromising conditions, particularly human immunodeficiency virus infection, were present in 41.3% of hospitalizations with strongyloidiasis. In-hospital death occurred in 7.8% of patients with strongyloidiasis-associated hospitalization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Strongyloidiasis-associated hospitalization is rare in the United States but can be associated with increased mortality rate\/mortality risk . It occurs more frequently in poor and marginalized populations. Immunocompromised conditions were common among hospitalized patients with strongyloidiasis. Enhanced surveillance efforts are needed to inform health policies for improving the health of at-risk populations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciac220","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T12:27:27Z","timestamp":1647520047000},"page":"1548-1555","source":"Crossref","is-referenced-by-count":14,"title":["Hospitalizations Associated With Strongyloidiasis in the United States, 2003\u20132018"],"prefix":"10.1093","volume":"75","author":[{"given":"Kengo","family":"Inagaki","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Michigan , Ann Arbor, Michigan , USA"},{"name":"Department of Pediatrics, University of Mississippi Medical Center , Jackson, Mississippi , USA"},{"name":"Department of Population Health Science, University of Mississippi Medical Center , Jackson, Mississippi , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S","family":"Bradbury","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences, Federation University , Berwick, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte V","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Mississippi Medical Center , Jackson, Mississippi , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"2022102916073273700_CIT0001","doi-asserted-by":"crossref","first-page":"e2288","DOI":"10.1371\/journal.pntd.0002288","article-title":"Strongyloides stercoralis: global distribution and risk factors.","volume":"7","author":"Schar","year":"2013","journal-title":"PLoS NeglTrop Dis"},{"key":"2022102916073273700_CIT0002","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/pathogens9060468","article-title":"The global prevalence of Strongyloides stercoralis infection.","volume":"9","author":"Buonfrate","year":"2020","journal-title":"Pathogens"},{"key":"2022102916073273700_CIT0003","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1017\/S0022149X16000213","article-title":"Strongyloidiasis in Latin American immigrants: a pilot study.","volume":"91","author":"Ostera","year":"2017","journal-title":"J Helminthol"},{"key":"2022102916073273700_CIT0004","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1086\/522529","article-title":"High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees.","volume":"45","author":"Posey","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2022102916073273700_CIT0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/bs.apar.2020.11.002","article-title":"HTLV-I and Strongyloides in Australia: the worm lurking beneath.","volume":"111","author":"Gordon","year":"2021","journal-title":"Adv Parasitol"},{"key":"2022102916073273700_CIT0006","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1371\/journal.pntd.0000256","article-title":"Neglected infections of poverty in the United States of America.","volume":"2","author":"Hotez","year":"2008","journal-title":"PLoS NeglTrop Dis"},{"key":"2022102916073273700_CIT0007","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4269\/ajtmh.18-0895","article-title":"Morbidity associated with chronic Strongyloides stercoralis infection: a systematic review and meta-analysis.","volume":"100","author":"Tamarozzi","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"2022102916073273700_CIT0008","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4269\/ajtmh.2011.11-0214","article-title":"Soil-transmitted helminthiasis in the United States: a systematic review\u20141940\u20132010.","volume":"85","author":"Starr","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"2022102916073273700_CIT0009","volume-title":"Overview of the National (Nationwide) Inpatient Sample (NIS)","author":"Healthcare Cost and Utilization Project (HCUP)."},{"key":"2022102916073273700_CIT0010","author":"US Census Bureau."},{"key":"2022102916073273700_CIT0011","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/QCO.0b013e3283551dbd","article-title":"Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis.","volume":"25","author":"Mejia","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"2022102916073273700_CIT0012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10096-005-0070-2","article-title":"Disseminated strongyloidiasis: a retrospective study of clinical course and outcome.","volume":"25","author":"Lam","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022102916073273700_CIT0013","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2334-13-78","article-title":"Severe strongyloidiasis: a systematic review of case reports.","volume":"13","author":"Buonfrate","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2022102916073273700_CIT0014","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijid.2020.09.002","article-title":"Modeling strongyloidiasis risk in the United States.","volume":"100","author":"Singer","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2022102916073273700_CIT0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4269\/ajtmh.1982.31.313","article-title":"Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States.","volume":"31","author":"Walzer","year":"1982","journal-title":"Am J Trop Med Hyg"},{"key":"2022102916073273700_CIT0016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archinte.1984.00350140135019","article-title":"Risk factors for strongyloidiasis. A case-control study.","volume":"144","author":"Davidson","year":"1984","journal-title":"Arch Intern Med"},{"key":"2022102916073273700_CIT0017","article-title":"Seroprevalence of Strongyloides stercoralis and evaluation of universal screening in kidney transplant candidates: a single-center experience in Houston (2012\u20132017).","volume":"6:ofz172","author":"Al-Obaidi","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2022102916073273700_CIT0018","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1399-3062.2010.00517.x","article-title":"Expanded infectious diseases screening program for Hispanic transplant candidates.","volume":"12","author":"Fitzpatrick","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"2022102916073273700_CIT0019","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4269\/ajtmh.2010.09-0750","article-title":"Strongyloidiasis-related deaths in the United States, 1991\u20132006.","volume":"83","author":"Croker","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"2022102916073273700_CIT0020","author":"US Census Bureau."},{"key":"2022102916073273700_CIT0021","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S2214-109X(18)30490-X","article-title":"Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis.","volume":"7","author":"Asundi","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2022102916073273700_CIT0022","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3389\/fpsyg.2020.01303","article-title":"Socioeconomic status and psychological well-being: revisiting the role of subjective socioeconomic status.","volume":"11","author":"Navarro-Carrillo","year":"2020","journal-title":"Front Psychol"},{"key":"2022102916073273700_CIT0023","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/0016-5085(81)90261-4","article-title":"Clinical features of Strongyloides stercoralis infection in an endemic area of the United States.","volume":"80","author":"Milder","year":"1981","journal-title":"Gastroenterology"},{"key":"2022102916073273700_CIT0024","first-page":"299","article-title":"Age-related prevalence of Strongyloides stercoralis infection in Okinawa, Japan.","volume":"44","author":"Arakaki","year":"1992","journal-title":"Trop Geogr Med"},{"key":"2022102916073273700_CIT0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4269\/ajtmh.2003.69.336","article-title":"High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries.","volume":"69","author":"Roman-Sanchez","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"2022102916073273700_CIT0026","article-title":"The unique life cycle of Strongyloides stercoralis and implications for public health action.","volume":"3","author":"Page","year":"2018","journal-title":"Trop Med Infect Dis"},{"key":"2022102916073273700_CIT0027","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3201\/eid1509.090191","article-title":"Reemergence of strongyloidiasis, Northern Italy.","volume":"15","author":"Abrescia","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2022102916073273700_CIT0028","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.actatropica.2006.06.006","article-title":"Is there an association between positive Strongyloides stercoralis serology and diabetes mellitus?","volume":"99","author":"Mendonca","year":"2006","journal-title":"Acta Trop"},{"key":"2022102916073273700_CIT0029","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.diabres.2015.01.012","article-title":"Does Strongyloides stercoralis infection protect against type 2 diabetes in humans? evidence from Australian Aboriginal adults.","volume":"107","author":"Hays","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"2022102916073273700_CIT0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.diabres.2017.09.012","article-title":"The relationship between treatment for Strongyloides stercoralis infection and type 2 diabetes mellitus in an Australian Aboriginal population: a three-year cohort study.","volume":"134","author":"Hays","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"2022102916073273700_CIT0031","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/cid\/ciy935","article-title":"Metabolic consequences of concomitant Strongyloides stercoralis infection in patients with type 2 diabetes mellitus.","volume":"69","author":"Rajamanickam","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022102916073273700_CIT0032","first-page":"1","article-title":"Revised surveillance case definition for HIV infection\u2014United States, 2014.","volume":"63","author":"Centers for Disease Control and Prevention.","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"2022102916073273700_CIT0033","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/QAD.0000000000000962","article-title":"Severe strongyloidiasis in AIDS: relative risk obscured by absolute rarity.","volume":"30","author":"Nadir","year":"2016","journal-title":"AIDS"},{"key":"2022102916073273700_CIT0034","doi-asserted-by":"crossref","first-page":"e1034","DOI":"10.1371\/journal.pntd.0001034","article-title":"High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States.","volume":"5","author":"Hochberg","year":"2011","journal-title":"PLoS NeglTrop Dis"},{"key":"2022102916073273700_CIT0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1179\/2047773212Y.0000000031","article-title":"Prevalence of Strongyloides stercoralis in an urban US AIDS cohort.","volume":"106","author":"Nabha","year":"2012","journal-title":"Pathog Glob Health"},{"key":"2022102916073273700_CIT0036","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/clinids\/21.3.675","article-title":"Strongyloidiasis in patients with hematologic malignancies.","volume":"21","author":"Nucci","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2022102916073273700_CIT0037","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4269\/ajtmh.2001.65.346","article-title":"The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies.","volume":"65","author":"Schaffel","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"2022102916073273700_CIT0038","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.20120","article-title":"Strongyloidiasis in patients at a comprehensive cancer center in the United States.","volume":"100","author":"Safdar","year":"2004","journal-title":"Cancer"},{"key":"2022102916073273700_CIT0039","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/ajt.13137","article-title":"Donor-derived Strongyloides stercoralis infection in solid organ transplant recipients in the United States, 2009-2013.","volume":"15","author":"Abanyie","year":"2015","journal-title":"Am J Transplant"},{"key":"2022102916073273700_CIT0040","doi-asserted-by":"crossref","first-page":"e13618","DOI":"10.1111\/ctr.13618","article-title":"Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"La Hoz","year":"2019","journal-title":"Clin Transplant"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac220\/43679406\/ciac220.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/9\/1548\/46684502\/ciac220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/9\/1548\/46684502\/ciac220.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T16:08:17Z","timestamp":1667059697000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/9\/1548\/6551689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,3,21]]},"published-print":{"date-parts":[[2022,10,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac220","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,3,21]]}}}